Clinical TrialsSearch results
Number of results: 227
Other
- Visceral Fat Accumulation and Coronary Artery Disease Investigation in Japan
- subjects in Ningen Dock, people who recieve routine medical checkups, and coronary artery disease patients
- Osaka University
- 2010-03-31
Other
- Good combination therapy, alpha-blocker and imidafenacin, for Nocturia of Benign Prostatic Hyperplasia with OAB in Osaka-Hokuriku study group.
- Overactive Bladder
- Osaka-Hokuriku maleLUTS Conference Secretariat
- 2009-08-17
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- The effects of Keishi-bukuryo-gan-ryo-ka-yokuinin on fatigue --- A placebo-controlled, double-blind study
- Easy fatigability
- Polyene Project, Ltd.
- 2008-11-28
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome
- membranous nephropathy with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Multicenter study for combined therapy of prednisolone and cyclosporin in refractory nephrotic syndrome
- membranouos nephropathy and focal segmental glomerulosclerosis with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease
- Kawasaki disease
- Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group
- 2008-01-27
Completed
- Phase III clinical trial of favipiravir in early-onset COVID-19 patients with severe risk factors
- COVID-19 patients with risk factors of progression to severe disease onset within 72 hours prior to
- Sakurai Tsutomu
- 2021-04-14
Other
- A prospective observation study concerning the incidence of atherothrombotic events in patients with acute coronary syndrome.
- Acute coronary syndrome
- Sanofi K.K.
- 2008-05-10